Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1983 May;52(2):287–292.

HLA-DR3 associated genetic control of response to multiple skin tests with new tuberculins.

W van Eden, R R de Vries, J L Stanford, G A Rook
PMCID: PMC1535848  PMID: 6407794

Abstract

Multiple skin testing with mycobacterial antigenic preparations reveals distinct reaction patterns, which might be relevant to the development of mycobacterial disease in man. Previous work has shown that HLA-DR associated factors correlate with the position of a leprosy patient in the immunopathological spectrum of leprosy. This study was undertaken to see whether these skin test patterns in healthy persons do show any association with HLA-DR types. Out of a group of 74 healthy Caucasoid individuals HLA-DR3 was observed to be absent from the 16 individuals who did not respond to any of the mycobacterial antigens tested. This is a striking difference from the distribution of HLA-DR3 both among the 17 individuals who responded to all mycobacterial antigens tested (P = 0.005) and the 41 individuals who responded to some but not all antigens (P = 0.015). These data show that an HLA-DR3 associated genetic factor controls, albeit indirectly, skin test responsiveness to mycobacterial antigens. It may be significant that this same HLA-DR determinant is implicated in deciding the type of disease to be developed by a leprosy patient.

Full text

PDF
289

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bianchi A. T., Hooijkaas H., Benner R., Tees R., Nordin A. A., Schreier M. H. Clones of helper T cells mediate antigen-specific, H-2-restricted DTH. Nature. 1981 Mar 5;290(5801):62–63. doi: 10.1038/290062a0. [DOI] [PubMed] [Google Scholar]
  2. Ellner J. J., Daniel T. M. Immunosuppression by mycobacterial arabinomannan. Clin Exp Immunol. 1979 Feb;35(2):250–257. [PMC free article] [PubMed] [Google Scholar]
  3. Fine P. E., Wolf E., Pritchard J., Watson B., Bradley D. J., Festenstein H., Chacko C. J. HLA-linked genes and leprosy: a family study in Karigiri, South India. J Infect Dis. 1979 Aug;140(2):152–161. doi: 10.1093/infdis/140.2.152. [DOI] [PubMed] [Google Scholar]
  4. Kaufmann S. H., Hahn H. Biological functions of t cell lines with specificity for the intracellular bacterium Listeria monocytogenes in vitro and in vivo. J Exp Med. 1982 Jun 1;155(6):1754–1765. doi: 10.1084/jem.155.6.1754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Lagrange P. H., Hurtrel B., Thickstun P. M. Immunological behavior after mycobacterial infection in selected lines of mice with high or low antibody responses. Infect Immun. 1979 Jul;25(1):39–47. doi: 10.1128/iai.25.1.39-47.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Legrand L., Rivat-Perran L., Huttin C., Dausset J. HLA-and Gm-linked genes affecting the degradation rate of antigens (sheep red blood cells) endocytized by macrophages. Hum Immunol. 1982 Feb;4(1):1–13. doi: 10.1016/0198-8859(82)90045-3. [DOI] [PubMed] [Google Scholar]
  7. Palmer C. E., Long M. W. Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis. Am Rev Respir Dis. 1966 Oct;94(4):553–568. doi: 10.1164/arrd.1966.94.4.553. [DOI] [PubMed] [Google Scholar]
  8. Paul R. C., Stanford J. L., Carswell J. W. Multiple skin testing in leprosy. J Hyg (Lond) 1975 Aug;75(1):57–68. doi: 10.1017/s0022172400047069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Rook G. A., Bahr G. M., Stanford J. L. The effect of two distinct forms of cell-mediated response to mycobacteria on the protective efficacy of BCG. Tubercle. 1981 Mar;62(1):63–68. doi: 10.1016/0041-3879(81)90038-6. [DOI] [PubMed] [Google Scholar]
  10. Shield M. J., Stanford J. L., Paul R. C., Carswell J. W. Multiple skin testing of tuberculosis patients with a range of new tuberculins, and a comparison with leprosy and Mycobacterium ulcerans infection. J Hyg (Lond) 1977 Jun;78(3):331–348. doi: 10.1017/s0022172400056230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Stanford J. L., Nye P. M., Rook G. A., Samuel N., Fairbank A. A preliminary investigation of the responsiveness or otherwise of patients and staff of a leprosy hospital to groups of shared or species antigens of mycobacteria. Lepr Rev. 1981 Dec;52(4):321–327. doi: 10.5935/0305-7518.19810043. [DOI] [PubMed] [Google Scholar]
  12. Strassmann G., Eshhar Z., Mozes E. Genetic regulation of delayed-type hypersensitivity responses to poly(LTyr,LGu)-poly(DLAla)--poly(LLys). I. Expression of the genetic defect at two phases of the immune process. J Exp Med. 1980 Feb 1;151(2):265–274. doi: 10.1084/jem.151.2.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Turk J. L., Bryceson A. D. Immunological phenomena in leprosy and related diseases. Adv Immunol. 1971;13:209–266. doi: 10.1016/s0065-2776(08)60185-6. [DOI] [PubMed] [Google Scholar]
  14. Wadee A. A., Sher R., Rabson A. R. Production of a suppressor factor by human adherent cells treated with mycobacteria. J Immunol. 1980 Sep;125(3):1380–1386. [PubMed] [Google Scholar]
  15. Yowell R. L., Araneo B. A., Miller A., Sercarz E. E. Amputation of a suppressor determinant on lysozyme reveals underlying T-cell reactivity to other determinants. Nature. 1979 May 3;279(5708):70–71. doi: 10.1038/279070a0. [DOI] [PubMed] [Google Scholar]
  16. Zinkernagel R. M., Althage A., Adler B., Blanden R. V., Davidson W. F., Kees U., Dunlop M. B., Shreffler D. C. H-2 restriction of cell-mediated immunity to an intracellular bacterium: effector T cells are specific for Listeria antigen in association with H-21 region-coded self-markers. J Exp Med. 1977 May 1;145(5):1353–1367. doi: 10.1084/jem.145.5.1353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. de Vries R. R., Fat R. F., Nijenhuis L. E., van Rood J. J. HLA-linked genetic control of host response to Mycobacterium leprae. Lancet. 1976 Dec 18;2(7999):1328–1330. doi: 10.1016/s0140-6736(76)91975-9. [DOI] [PubMed] [Google Scholar]
  18. de Vries R. R., Mehra N. K., Vaidya M. C., Gupte M. D., Meera Khan P., Van Rood J. J. HLA-linked control of susceptibility to tuberculoid leprosy and association with HLA-DR types. Tissue Antigens. 1980 Oct;16(4):294–304. doi: 10.1111/j.1399-0039.1980.tb00309.x. [DOI] [PubMed] [Google Scholar]
  19. van Eden W., de Vries R. R., D'Amaro J., Schreuder I., Leiker D. L., van Rood J. J. HLA-DR-associated genetic control of the type of leprosy in a population from surinam. Hum Immunol. 1982 Jul;4(4):343–350. doi: 10.1016/0198-8859(82)90007-6. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES